Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 21, 2014; 20(39): 14156-14171
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14156
Published online Oct 21, 2014. doi: 10.3748/wjg.v20.i39.14156
Stage of CHB | Markers of stage | T cell subsets | ||||
Th1 | Th2 | Th17 | Treg | CTL | ||
Immune tolerance stage | HBsAg+ HBeAg+ HBeAb- HBV DNA + ALT normal Liver histology: normal or mild inflammation[56] | Inactive HBe/HBc-specific Th1[53] | Predominance of HBeAg-specific Th2 cells. Predominance of anti-inflammatory cytokines - IL-4, IL-5, IL-10[53,56] | Significant accumulation of CD4+CD25+ FoxP3+ Treg cells in the liver. CD8+ CTLA-4+ FoxP3+ Treg cells present[117] | ||
Immune clearance stage | HBsAg+ HBeAg+ HBeAb- HBV DNA + ALT ↑ Liver histology: active inflammation[56] | Intrahepatic CD4+ T cells are mostly Th1 cells. Predominance of IL-2, IFNγ, TNFα cytokines[141] | Inactive HBe-specific Th2 clones with low avidity[141] | High content of Th17 in the liver[126] and in the blood[127] | Treg cells elevate in the beginning and then fall in the liver and elevate in the blood[123,128,132] | HBcAg-specific CD8+ CTLs increase in the liver[34] but not in the blood[56,142] |
Inactive HBsAg carrier stage | HBsAg+ HBeAg- HBeAb+ HBV DNA+ ALT normal/↑ | Predominance of inflammatory Th1 cells[56] | HBV-specific central memory CD8+ T cell response[143] | |||
Liver histology: mild inflammation or inactive cirrhosis[56] | Low HBV-specific immune responses[84] | |||||
Reactivation stage | HBsAg+ HBeAg- HBeAb+ HBV DNA +/- ALT normal/↑ Liver histology: from normal to cirrhosis and hepatocellular carcinoma[56] | Predominance of inflammatory Th1 cells[56] | HBeAg-specific Th2 cells fall down[56] | CD8+ CTLs fall down[144] | ||
Anergy of HBc/HBeAg and HBeAg specific T-cells in the liver[117] Serum cytokine levels (interferon IFNγ, TNFα, IL-1β, IL-4, IL-12, IL-10, IL-2, IL-5, IL-8) are evaluated[145] |
- Citation: Balmasova IP, Yushchuk ND, Mynbaev OA, Alla NR, Malova ES, Shi Z, Gao CL. Immunopathogenesis of chronic hepatitis B. World J Gastroenterol 2014; 20(39): 14156-14171
- URL: https://www.wjgnet.com/1007-9327/full/v20/i39/14156.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i39.14156